Drug Shortage Report for BENZTROPINE
Report ID | 201890 |
Drug Identification Number | 02486822 |
Brand name | VPI-BENZTROPINE |
Common or Proper name | BENZTROPINE MESYLATE |
Company Name | PHEBRA PTY LTD |
Market Status | DORMANT |
Active Ingredient(s) | BENZTROPINE MESYLATE |
Strength(s) | 2MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
Packaging size | Vials of 2 ml, boxes of 10 |
ATC code | N04AC |
ATC description | ANTICHOLINERGIC AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-03-30 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2023-10-11 |
Company comments | The estimated end date is unknown due to an ongoing administrative change (DIN transfer in progress). |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 19, ORION ROAD LANE COVE WEST, NEW SOUTH WALES AUSTRALIA 2066 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2023-10-11 | French | Compare |
v5 | 2023-10-11 | English | Compare |
v4 | 2023-10-11 | French | Compare |
v3 | 2023-10-11 | English | Compare |
v2 | 2023-08-15 | French | Compare |
v1 | 2023-08-15 | English | Compare |
Showing 1 to 6 of 6